Maravai Lifesciences Holdings (MRVI) Asset Writedowns and Impairment (2025 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Asset Writedowns and Impairment of $605000.0 in Q1 2026, down 87.65% quarter-over-quarter from $4.9 million in Q4 2025, and down 95.13% on a YoY basis from $12.4 million in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Asset Writedowns and Impairment (2025 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $605000.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 605,000.00 |
| Mar 31, 2026 | 605,000.00 |
| Dec 31, 2025 | 4.90 Mn |
| Dec 31, 2025 | 4.90 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Mar 31, 2025 | 12.44 Mn |